Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clin Neurol Neurosurg ; 206: 106629, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1261867

ABSTRACT

Pineal anlage tumor (PAT) is an extremely rare tumor of paediatric population. It is considered as a subtype of pineoblastoma having ectomesenchymal/ rhabdomyoblastic and cartilaginous differentiation. PAT is presumed to have an aggressive behaviour with propensity for craniospinal fluid (CSF) spread due to histologically resemblance with pineoblastoma, thus requiring intensive multimodality treatment with craniospinal irradiation and chemotherapy. Here we report a case of PAT in a 35 years old lady along with clinical and pathological review. To the best of our knowledge only less than ten cases of pineal anlage tumors have been reported in the literature and index case is only second in the adult age group (rare histology in rare age group).


Subject(s)
Brain Neoplasms/pathology , Neuroectodermal Tumor, Melanotic/pathology , Pineal Gland/pathology , Pinealoma/pathology , Adult , Female , Humans
2.
Neurosurg Focus ; 49(6): E7, 2020 12.
Article in English | MEDLINE | ID: covidwho-953401

ABSTRACT

OBJECTIVE: COVID-19 has affected surgical practice globally. Treating neurosurgical patients with the restrictions imposed by the pandemic is challenging in institutions with shared patient areas. The present study was performed to assess the changing patterns of neurosurgical cases, the efficacy of repeated testing before surgery, and the prevalence of COVID-19 in asymptomatic neurosurgical inpatients. METHODS: Cases of non-trauma-related neurosurgical patients treated at the Postgraduate Institute of Medical Education and Research (PGIMER) before and during the COVID-19 pandemic were reviewed. During the pandemic, all patients underwent a nasopharyngeal swab reverse transcription-polymerase chain reaction test to detect COVID-19 at admission. Patients who needed immediate intervention were surgically treated following a single COVID-19 test, while stable patients who initially tested negative for COVID-19 were subjected to repeated testing at least 5 days after the first test and within 48 hours prior to the planned surgery. The COVID-19 positivity rate was compared with the local period prevalence. The number of patients who tested positive at the second test, following a negative first test, was used to determine the probable number of people who could have become infected during the surgical procedure without second testing. RESULTS: Of the total 1769 non-trauma-related neurosurgical patients included in this study, a mean of 337.2 patients underwent surgery per month before COVID-19, while a mean of 184.2 patients (54.6% of pre-COVID-19 capacity) underwent surgery per month during the pandemic period, when COVID-19 cases were on the rise in India. There was a significant increase in the proportion of patients undergoing surgery for a ruptured aneurysm, stroke, hydrocephalus, and cerebellar tumors, while the number of patients seeking surgery for chronic benign diseases declined. At the first COVID-19 test, 4 patients (0.48%) tested were found to have the disease, a proportion 3.7 times greater than that found in the local community. An additional 5 patients tested positive at the time of the second COVID-19 test, resulting in an overall inpatient period prevalence of 1%, in contrast to a 0.2% national cumulative caseload. It is possible that COVID-19 was prevented in approximately 67.4 people every month by using double testing. CONCLUSIONS: COVID-19 has changed the pattern of neurosurgical procedures, with acute cases dominating the practice. Despite the fact that the pandemic has not yet reached its peak in India, COVID-19 has been detected 3.7 times more often in asymptomatic neurosurgical inpatients than in the local community, even with single testing. Double testing displays an incremental value by disclosing COVID-19 overall in 1 in 100 inpatients and thus averting its spread through neurosurgical services.


Subject(s)
COVID-19 Nucleic Acid Testing/trends , COVID-19/diagnosis , COVID-19/epidemiology , Hospitalization/trends , Neurosurgical Procedures/trends , Adolescent , Adult , Aged , COVID-19 Nucleic Acid Testing/standards , Child, Preschool , Female , Humans , India/epidemiology , Male , Middle Aged , Neurosurgical Procedures/standards , Prevalence , Treatment Outcome
3.
Neurol India ; 68(5): 1008-1011, 2020.
Article in English | MEDLINE | ID: covidwho-895443

ABSTRACT

BACKGROUND: The world is in the midst of the COVID crisis, which has forced the neurosurgical community to change its practices. OBJECTIVE: To advocate the necessary adaptations in radio surgical practices to effectively manage the radio surgical patients, resource utilization, and protecting the healthcare provider during the COVID pandemic. MATERIAL AND METHODS: In addition to the literature review, pertinent recommendations are made in respect to the gamma knife radiosurgery (GKRS). RESULTS: Every patient presenting to GKRS treatment should be considered as a potential asymptomatic COVID carrier. Patients should be categorized based on the priority (urgent, semi-urgent, or elective) on the basis of pathological and clinical status. The only urgent indication is a non-responding or enlarging cerebral metastasis. There is a high risk of aerosol dispersion during gamma radiation delivery in the gamma gantry. CONCLUSION: These recommendations should be used to minimize the chances of pathogenic exposure to the patient and caregivers both.


Subject(s)
COVID-19 , Radiosurgery , Humans , SARS-CoV-2 , Treatment Outcome
4.
Neurol India ; 68(4): 774-791, 2020.
Article in English | MEDLINE | ID: covidwho-732745

ABSTRACT

INTRODUCTION: Severe acute respiratory syndrome, coronavirus 2 (SARS-COV 2) has inexplicably and irreversibly changed the way of neurosurgery practice. There has been a substantial reduction in neurosurgical operations during the period of lockdown. The lockdown might be the most effective measure to curtail viral transmission. Once we return to the normalization of the lifestyle, there will be a backlog of unoperated pending cases along with the possibility of further spread of the coronavirus. METHODS: We reviewed the available literature and protocols for neurosurgical practice in different geographic locations. We drafted a consensus statement based on the literature and protocols suggested by the World Health Organization (WHO) and various professional societies to prevent the spread of SARS-COV2 while streamlining the neurosurgical practice. RESULTS: The consensus statement suggests the patient triage, workflow, resource distribution, and operational efficacy for care providers at different stages of management. The priority is set at personal protection while ensuring patients' safety, timely management, and capacity building. We performed a detailed subsection analysis for the management of trauma and set up for COVID-free hospitals for simultaneous management of routine neurosurgical indications. In this time of medicolegal upheaval, special consent from the patients should be taken in view of the chances of delay in management and the added risk of corona infection. The consensus statements are applicable to neurosurgical setups of all capacities. CONCLUSION: Along with the glaring problem of infection, there is another threat of neurosurgery emergency building up. This wave may overwhelm the already stretched systems to the hilt. We need to flatten this curve while avoiding contagion. These measures may guide neurosurgery practitioners to effectively manage patients ensuring the safety of caregivers and care seekers both.


Subject(s)
Betacoronavirus/pathogenicity , Consensus , Coronavirus Infections/prevention & control , Neurosurgery , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , COVID-19 , Caregivers , Coronavirus Infections/surgery , Humans , Neurosurgery/methods , Neurosurgical Procedures , Pneumonia, Viral/surgery , SARS-CoV-2
5.
Stereotact Funct Neurosurg ; 98(5): 358-360, 2020.
Article in English | MEDLINE | ID: covidwho-711083
SELECTION OF CITATIONS
SEARCH DETAIL